Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 280.21
-0.29 (-0.10%)
Jul 28, 2026, 8:05 AM GMT
AIM:AMS Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 228.94 | 177.52 | 126.21 | 124.33 | 108.6 | |
Revenue Growth | 28.96% | 40.66% | 1.51% | 14.48% | 25.12% |
Cost of Revenue | 106.8 | 84.9 | 56.07 | 50.91 | 47.53 |
Gross Profit | 122.14 | 92.62 | 70.14 | 73.42 | 61.07 |
Selling, General & Admin | 100.15 | 82.31 | 52.19 | 49 | 38.45 |
Other Operating Expenses | -0.67 | -0.91 | -0.93 | -0.48 | -0.38 |
Operating Expenses | 99.48 | 81.4 | 51.26 | 48.53 | 38.07 |
Operating Income | 22.66 | 11.22 | 18.88 | 24.89 | 23 |
Interest Expense | -5.05 | -3.56 | -0.38 | -0.64 | -0.67 |
Interest & Investment Income | 0.21 | 1.29 | 2.47 | 0.82 | 0.08 |
Other Non Operating Income (Expenses) | -0.04 | 0.87 | 0.19 | 0.84 | -0.43 |
EBT Excluding Unusual Items | 17.78 | 9.82 | 21.16 | 25.91 | 21.98 |
Pretax Income | 17.78 | 9.82 | 21.16 | 25.91 | 21.98 |
Income Tax Expense | 7.69 | 2.68 | 5.27 | 5.5 | 4.5 |
Earnings From Continuing Operations | 10.1 | 7.14 | 15.89 | 20.41 | 17.48 |
Minority Interest in Earnings | -0.14 | -0.05 | - | - | - |
Net Income | 9.95 | 7.09 | 15.89 | 20.41 | 17.48 |
Net Income to Common | 9.95 | 7.09 | 15.89 | 20.41 | 17.48 |
Net Income Growth | 40.32% | -55.35% | -22.14% | 16.73% | 103.65% |
Shares Outstanding (Basic) | 216 | 214 | 216 | 217 | 216 |
Shares Outstanding (Diluted) | 220 | 218 | 219 | 219 | 218 |
Shares Change | 0.78% | -0.45% | -0.09% | 0.53% | 0.22% |
EPS (Basic) | 0.05 | 0.03 | 0.07 | 0.09 | 0.08 |
EPS (Diluted) | 0.05 | 0.03 | 0.07 | 0.09 | 0.08 |
EPS Growth | 39.08% | -55.17% | -22.04% | 16.11% | 103.30% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 25.23 | 15.43 | 8.8 | 23.14 | 29.26 |
Free Cash Flow Per Share | 0.12 | 0.07 | 0.04 | 0.10 | 0.13 |
Dividend Per Share | 0.029 | 0.026 | 0.024 | 0.021 | 0.019 |
Dividend Growth | 10.00% | 10.17% | 9.77% | 10.26% | 14.71% |
Gross Margin | 53.35% | 52.17% | 55.57% | 59.05% | 56.23% |
Operating Margin | 9.90% | 6.32% | 14.96% | 20.02% | 21.18% |
Profit Margin | 4.35% | 4.00% | 12.59% | 16.41% | 16.10% |
Free Cash Flow Margin | 11.02% | 8.69% | 6.97% | 18.61% | 26.94% |
EBITDA | 37.04 | 22.7 | 26.6 | 30.94 | 28.67 |
EBITDA Margin | 16.18% | 12.79% | 21.07% | 24.89% | 26.40% |
D&A For EBITDA | 14.38 | 11.48 | 7.71 | 6.05 | 5.67 |
EBIT | 22.66 | 11.22 | 18.88 | 24.89 | 23 |
EBIT Margin | 9.90% | 6.32% | 14.96% | 20.02% | 21.18% |
Effective Tax Rate | 43.23% | 27.29% | 24.90% | 21.24% | 20.48% |